To the best of our knowledge, this is the first report to demonstrate a positive correlation between the co-expression of ERβ with p53 protein and clinical outcomes in patients with endometrial endometrioid carcinoma. The gene discussed is ESR2; the disease is endometrial endometrioid carcinoma.